NEW YORK (GenomeWeb) – Imperial College London has launched a new branch of the Parkinson's Progression Markers Initiative, a large-scale biomarker research project sponsored by the Michael J. Fox Foundation for Parkinson's Research that will focus on two mutations linked to the disease, the foundation said today.

The PPMI will study individuals with known LRRK or SNCA genetic mutations, both of which have been linked to Parkinson's disease, and it is currently seeking volunteers of Ashkenazi Jewish background to participate in the project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.